We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Detection of the Disorders of Glycerophospholipids and Amino Acids Metabolism in Lung Tissue From Male COPD Patients
Summary
Untargeted metabolomics was applied to lung tissue from male COPD patients to characterize metabolic disruptions, finding significant disturbances in glycerophospholipid and amino acid metabolism compared to healthy controls. The study identifies overlapping biomarkers between lung tissue and plasma metabolomes, suggesting that blood-based metabolic profiling could serve as a surrogate for lung metabolic status in COPD.
Background: At present, few studies have reported the metabolic profiles of lung tissue in patients with COPD. Our study attempted to analyze the lung metabolome in male COPD patients and to screen the overlapping biomarkers of the lung and plasma metabolomes. Methods: We performed untargeted metabolomic analysis of normal lung tissue from two independent sets (the discovery set: 20 male COPD patients and 20 controls and the replication set: 47 male COPD patients and 27 controls) and of plasma samples from 80 male subjects containing 40 COPD patients and 40 controls. Results: We found glycerophospholipids (GPs) and Amino acids were the primary classes of differential metabolites between male COPD patients and controls. The disorders of GPs metabolism and the valine, leucine and isoleucine biosynthesis metabolism pathways were identified in lung discovery set and then also validated in the lung replication set. Combining lung tissue and plasma metabolome, Phytosphingosine and l-tryptophan were two overlapping metabolites biomarkers. Binary logistic regression suggested that phytosphingosine together with l-tryptophan was closely associated with male COPD and showed strong diagnostic power with an AUC of 0.911 (95% CI: 0.8460-0.9765). Conclusion: Our study revealed the metabolic perturbations of lung tissues from male COPD patients. The detected disorders of GPs and amino acids may provide an insight into the pathological mechanism of COPD. Phytosphingosine and l-tryptophan were two novel metabolic biomarkers for differentiating COPD patients and controls.
Sign in to start a discussion.
More Papers Like This
Targeted metabolomics reveals differential biological effects of nanoplastics and nanoZnO in human lung cells
Researchers used targeted metabolomics to compare how nanoplastics and zinc oxide nanoparticles affect human lung cells at the molecular level. Even at concentrations that did not cause obvious cell death, both types of nanoparticles significantly disrupted cell metabolism, though through different biochemical pathways. The study suggests that standard toxicity tests may underestimate the harmful effects of nanoplastics on human respiratory cells.
A metabolomics perspective on the effect of environmental micro and nanoplastics on living organisms: A review
This review examines how scientists use metabolomics, the study of small molecules produced by cellular processes, to understand the toxic effects of microplastics and nanoplastics on living organisms. The research shows that these plastic particles disrupt metabolism in consistent ways across species, affecting energy production, fat processing, and amino acid pathways. These shared metabolic disruptions across different organisms suggest that microplastics could cause similar metabolic problems in humans.
Integration of transcriptomics and metabolomics reveal cytotoxic mechanisms of Polyethylene terephthalate microplastics in BEAS-2B cells
Researchers exposed human lung cells to PET microplastics and used combined gene and metabolite analysis to uncover the mechanisms of toxicity. They found that the microplastics disrupted lipid metabolism and activated cell death pathways, reducing cell viability over time. The study suggests that inhaled PET microplastics could pose risks to respiratory health by triggering harmful molecular changes in lung tissue.
Polystyrene nanoplastics induced lung injury in mice: Insights into lung metabolic disorders
Researchers exposed mice to polystyrene nanoplastics through the airway and found that the particles caused lung inflammation and tissue damage. Using metabolomics analysis, they discovered that the nanoplastics disrupted multiple metabolic pathways in lung tissue, with surface-modified particles causing more severe effects. The study provides evidence that inhaled nanoplastics can alter lung metabolism in ways that may contribute to respiratory health problems.
Investigation of the presence of microplastics and their clinical significance in patients with exacerbation and stable periods of chronic obstructive pulmonary disease
Researchers examined the presence of microplastics in sputum and bronchoalveolar lavage samples from chronic obstructive pulmonary disease (COPD) patients during exacerbation and stable phases. MPs were detected in a majority of patient samples, and their presence was associated with greater airway inflammation, suggesting inhaled microplastics contribute to COPD pathology.